4-Oxo-1,4-dihydropyridines as selective CB₂ cannabinoid receptor ligands. Part 2: discovery of new agonists endowed with protective effect against experimental colitis.

Citation: El Bakali J, Gilleron P, Body-Malapel M, Mansouri R, Muccioli GG, Djouina M, Barczyk A, Klupsch F, Andrzejak V, Lipka E, Furman C, Lambert DM, Chavatte P, Desreumaux P, Millet R.: 4-Oxo-1,4-dihydropyridines as selective CB₂ cannabinoid receptor ligands. Part 2: discovery of new agonists endowed with protective effect against experimental colitis. J Med Chem, Volume 55 (20), 2012
Authors: Andrzejak V, Barczyk A, Body-Malapel M, Chavatte P, Desreumaux P, Djouina M, El Bakali J, Furman C, Gilleron P, Klupsch F, Lambert DM, Lipka E, Mansouri R, Millet R., Muccioli GG
Journal: J Med Chem
Year: 2012
DOI: 10.1021/jm3008568
PubMed: 23017078
Machine-readable: REST API RDF

Publication